After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...

Patients who were prescribed drugs for restless legs syndrome (RLS) have said doctors did not warn them about significant ...

Secondary endpoint analyses from the trials showed 'significant improvements' in patients treated with the antibody.

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its ...

Medical breakthroughs and regulatory approvals ... beating its benchmark by 218 percentage points (see more details here).

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best vaccine stocks to buy now. On February 24, CNBC reported that President Trump declared that ...

Global healthcare communications company, Porterhouse Medical announced the appointment of Michael Tague ... Lynch has been elected to its board of directors, effective February 19. GSK announced Dr.

Under the terms of this agreement, we granted GSK a worldwide, royalty-bearing antibody sequence ... therapeutics targeting novel pathways in areas of significant unmet medical need. Phase 1 studies ...